Oglala Sioux Tribe Reports Three Members in ICE Custody Following Minneapolis ArrestsJanuary 14, 2026
Oglala Sioux Tribe Reports Three Members in ICE Custody Following Minneapolis ArrestsJanuary 14, 2026
First Leukemia Patient Undergoes Groundbreaking NHS Treatment Describing It as Like Science FictionJanuary 14, 2026
A Bittersweet Goodbye: BioWare’s Destiny-inspired Game Closes Its Doors with Nostalgic FarewellJanuary 12, 2026
Tesla Shifts to Subscription Model for Full Self-Driving: Implications of this Bold ChangeJanuary 14, 2026
Historic Victory: First American Man Claims Chevron Houston Marathon Title Since 2002January 13, 2026
January Rains in Liberia Highlight Deepening Climate Crisis, Warns Environmental AgencyJanuary 13, 2026
Wegovy Shows Continued Weight Loss Success After Zepbound Business December 18, 2025 Eli Lilly announced that its obesity drug, Orforglipron, has shown promise in helping patients maintain weight loss after transitioning from…
Eli Lilly’s Letartortide Achieves Success in First Late-Stage Weight Loss Trial Business December 11, 2025 Eli Lilly announced promising results for its next-generation obesity drug, letaltortide, revealing it achieved the highest weight loss ever recorded…
FDA Greenlights SIGNOS Glucose Monitoring for Effective Weight Loss Solutions Business August 20, 2025 The FDA has approved SIGNOS, a glucose monitoring system from Cygnos, specifically designed for weight loss, providing a new option…
Eli Lilly Takes Legal Action Against Competitors in Weight Loss Drug Market Business April 24, 2025 Eli Lilly & Co., the manufacturer of the weight loss drug Zepbound, is suing four telehealth companies for allegedly selling…
